Cargando…
A core outcome set for clinical trials of Chinese medicine for hyperlipidemia: a study protocol for a systematic review and a Delphi survey
BACKGROUND: Hyperlipidemia, defined as elevated lipid levels, is the primary and major risk factor for atherosclerotic cardiovascular disease. Several studies have evaluated the effects of Chinese medicine (CM) on hyperlipidemia. However, due to the varied designs and methods of these studies, data...
Autores principales: | Li, Geng, Zhou, Li, Ouyang, Wenwei, Xuan, Meiling, Lu, Liming, Li, Xiaoyan, Wen, Zehuai, Chen, Xiankun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322321/ https://www.ncbi.nlm.nih.gov/pubmed/30612586 http://dx.doi.org/10.1186/s13063-018-3082-9 |
Ejemplares similares
-
Developing a Core Outcome Set for Clinical Trials of Chinese Medicine for Hyperlipidemia
por: Li, Geng, et al.
Publicado: (2022) -
Outcome Reporting Variability in Trials of Chinese Medicine for Hyperlipidemia: A Systematic Review for Developing a Core Outcome Set
por: Li, Geng, et al.
Publicado: (2021) -
A statistical analysis plan for the efficiency and safety of Chinese herbal medicine used concurrently with topical therapy for psoriasis vulgaris
por: Lu, Liming, et al.
Publicado: (2016) -
Chinese Herbal Formula Huoxiang Zhengqi for Dampness Pattern in Atopic Dermatitis and Diarrhea-Predominant Irritable Bowel Syndrome: Rationale and Design of a Master Protocol
por: Huang, Qian, et al.
Publicado: (2021) -
The Chinese herbal formula Huoxiang Zhengqi for atopic dermatitis with dampness pattern (CHARM): a study protocol for a double-blinded randomized controlled trial
por: Xuan, Meiling, et al.
Publicado: (2021)